IMAX China Holding, Inc. filed its Monthly Return for the period ended 31 May 2026, confirming no changes to its authorised, issued or treasury share balances during the month.

The company’s authorised share capital remained at 625.63 million ordinary shares with a par value of USD 0.0001 each, translating to total authorised capital of USD 62,562.50. Issued shares were unchanged at 339.89 million, and the issuer continued to hold no treasury shares.

IMAX China affirmed compliance with Hong Kong Main Board Rule 13.32, maintaining a public float of at least 25 percent of its issued shares as of 31 May 2026.

No share options were exercised and no new shares were issued in May. Under the Post-IPO Share Option Scheme (approved 7 June 2023), 242,584 options remained outstanding, representing the same number of shares that could be issued upon exercise. The scheme still carries capacity for up to 31.41 million additional shares. The company also reported no activity under its Post-IPO Restricted Share Unit Scheme during the month.

No warrants, convertible securities, share buy-backs, or additional share-issuance arrangements were executed. Consequently, both total issued shares and treasury share balances were unchanged through the reporting period.

The filing was authorised by Joint Company Secretary Yifan (Yvonne) He and submitted to Hong Kong Exchanges and Clearing Limited on 1 June 2026.